| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.8K | $3.74M | - | |
| Other | 133.1K | $3.37M | - | |
| CEO | 132.7K | $3.36M | - | |
| CFO | 105.7K | $2.68M | - | |
| VP | 95.7K | $2.42M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2016 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $50.85 | $1,016,908.50 | -1.9% | |
| Jun 20, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 650 | $54.16 | $35,204.00 | -5.8% | |
| May 24, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 650 | $66.00 | $42,900.00 | -8.4% | |
| May 16, 2016 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $59.95 | $1,199,094.65 | -1.0% | |
| Apr 20, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 649 | $70.53 | $45,773.97 | -7.0% | |
| Apr 15, 2016 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $70.33 | $1,406,553.86 | -1.2% | |
| Mar 22, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 650 | $61.45 | $39,942.50 | -6.3% | |
| Feb 22, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 658 | $63.48 | $41,769.84 | -5.8% | |
| Jan 20, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 585 | $72.83 | $42,605.55 | -4.6% | |
| Dec 31, 2015 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $114.52 | $2,290,491.27 | -0.5% |